Kuo, C.-Y.; Tsai, M.-J.; Hung, J.-Y.; Wu, K.-L.; Tsai, Y.-M.; Tsai, Y.-C.; Chuang, C.-H.; Lee, T.-H.; Chen, H.-C.; Yang, C.-J.;
et al. Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes. Cancers 2023, 15, 187.
https://doi.org/10.3390/cancers15010187
AMA Style
Kuo C-Y, Tsai M-J, Hung J-Y, Wu K-L, Tsai Y-M, Tsai Y-C, Chuang C-H, Lee T-H, Chen H-C, Yang C-J,
et al. Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes. Cancers. 2023; 15(1):187.
https://doi.org/10.3390/cancers15010187
Chicago/Turabian Style
Kuo, Chia-Yu, Ming-Ju Tsai, Jen-Yu Hung, Kuan-Li Wu, Ying-Ming Tsai, Yu-Chen Tsai, Cheng-Hao Chuang, Tai-Huang Lee, Huang-Chi Chen, Chih-Jen Yang,
and et al. 2023. "Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes" Cancers 15, no. 1: 187.
https://doi.org/10.3390/cancers15010187
APA Style
Kuo, C. -Y., Tsai, M. -J., Hung, J. -Y., Wu, K. -L., Tsai, Y. -M., Tsai, Y. -C., Chuang, C. -H., Lee, T. -H., Chen, H. -C., Yang, C. -J., & Chong, I. -W.
(2023). Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes. Cancers, 15(1), 187.
https://doi.org/10.3390/cancers15010187
